18F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma

被引:18
|
作者
Murakami, Shuji [1 ]
Saito, Haruhiro [1 ]
Karino, Fumi [1 ]
Kondo, Tetsuro [1 ]
Oshita, Fumihiro [1 ]
Ito, Hiroyuki [1 ]
Nakayama, Haruhiko [1 ]
Yokose, Tomoyuki [2 ]
Yamada, Kouzo [1 ]
机构
[1] Kanagawa Canc Ctr Hosp, Dept Thorac Oncol, Yokohama, Kanagawa 2410815, Japan
[2] Kanagawa Canc Ctr Hosp, Dept Pathol, Yokohama, Kanagawa 2410815, Japan
关键词
Mucinous adenocarcinoma; TS-CT; FDG-PET; maxSUV; CELL LUNG-CANCER; FDG-PET FINDINGS; BRONCHIOLOALVEOLAR CARCINOMA; COMPUTED-TOMOGRAPHY; SURGICAL RESECTION; CT; CHEMORADIOTHERAPY; DIFFERENTIATION; HISTOPATHOLOGY; RECURRENCE;
D O I
10.1016/j.ejrad.2013.07.028
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The prognostic value of maximum standardized uptake value (maxSUV) on F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) is known for localized pulmonary adenocarcinoma, which is most commonly non-mucinous adenocarcinoma. We examined the validity of thin-section computed tomography (TS-CT) and FDG-PET findings in mucinous adenocarcinoma. Materials and Methods: TS-CT and FDG-PET were performed on 25 patients with mucinous lung adenocarcinoma that was subsequently resected between January 2009 and March 2013. Based on the percentage reduction of maximum tumor diameter on the mediastinal window image compared with the diameter on the lung window image on TS-CT, tumors were classified as air-type (>= 50%) or solid-type (<50%). All resected specimens were pathologically diagnosed according to the International Association for the Study of Lung Cancer (IASLC) classification, and the diameter of the pathological invasive area was assessed. Results: Most mucinous adenocarcinomas were located in the lower lobe. All except two were classified as solid-type tumor on TS-CT. Multiple regression analysis revealed the correlation of maxSUV with pathological tumor size and diameter of pathological invasive area; these two parameters showed no significant correlation with each other (r = 0.354, p = 0.083). maxSUV was significantly lower for tumors with invasive area <= 5 mm than for tumors with invasive area >5 mm (1.62 vs. 3.77, p = 0.01), but no statistically significant difference was found in terms of other pathological invasive findings such as the presence of lymphatic or vascular invasion, pleural involvement, or predominant histological subtype. Conclusions: Most mucinous adenocarcinomas had appearances of solid-type tumor on TS-CT. maxSUV on FDG-PET indicates the pathological invasive area in mucinous adenocarcinoma as well as non-mucinous adenocarcinoma. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:E721 / E725
页数:5
相关论文
共 50 条
  • [41] Pulmonary artery intimal sarcoma: poor 18F-fluorodeoxyglucose uptake in positron emission computed tomography
    Dong-Hyup Lee
    Tae-Eun Jung
    Jang-Hoon Lee
    Dong-Gu Shin
    Won-Jong Park
    Jun-Hyuk Choi
    Journal of Cardiothoracic Surgery, 8
  • [42] Utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in cardiac infections
    Jaleel, Jasim
    Kaushik, Prateek
    Patel, Chetan
    Chandra, Khangembam Bankim
    Yadav, Satyavir
    Siddharthan, Deepti
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2023, 38 (02): : 140 - 144
  • [43] 18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer
    Thomas Poisson
    Désirée Deandreis
    Sophie Leboulleux
    François Bidault
    Guillaume Bonniaud
    Sylvain Baillot
    Anne Aupérin
    Abir Al Ghuzlan
    Jean-Paul Travagli
    Jean Lumbroso
    Eric Baudin
    Martin Schlumberger
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 2277 - 2285
  • [44] 18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer
    Poisson, Thomas
    Deandreis, Desiree
    Leboulleux, Sophie
    Bidault, Francois
    Bonniaud, Guillaume
    Baillot, Sylvain
    Auperin, Anne
    Al Ghuzlan, Abir
    Travagli, Jean-Paul
    Lumbroso, Jean
    Baudin, Eric
    Schlumberger, Martin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) : 2277 - 2285
  • [45] Effect of metformin on 18F-fluorodeoxyglucose uptake and positron emission tomographic imaging
    Zhang, Xieyi
    Ogihara, Takuo
    Zhu, Min
    Gantumur, Dolgormaa
    Li, Yang
    Mizoi, Kenta
    Kamioka, Hiroki
    Tsushima, Yoshito
    BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1130):
  • [46] 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging
    Giraudo, Chiara
    Raderer, Markus
    Karanikas, Georgios
    Weber, Michael
    Kiesewetter, Barbara
    Dolak, Werner
    Simonitsch-Klupp, Ingrid
    Mayerhoefer, Marius E.
    INVESTIGATIVE RADIOLOGY, 2016, 51 (03) : 163 - 169
  • [47] The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Treatment of Brain Abscess
    Park, Seong-Hyun
    Lee, Sang-Woo
    Kang, Dong-Hun
    Hwang, Jeong-Hyun
    Sung, Joo-Kyung
    Hwang, Sung-Kyoo
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2011, 49 (05) : 278 - 283
  • [48] Usefulness of positron emission tomography with 18F-fluorodeoxyglucose in Still's disease
    Cabrera Villegas, Antonio
    Rosel Rioja, Luis Felipe
    Ramirez Lasanta, Rafael
    MEDICINA CLINICA, 2017, 148 (03): : 140 - 141
  • [49] Usefulness of 18F-fluorodeoxyglucose positron emission tomography in follicular lymphoma management
    Le Dortz, L.
    de Guibert, S.
    Devillers, A.
    Rolland, Y.
    Bayat, S.
    Prigent, F.
    Bahri, H.
    Hervouet, T.
    Lamy, T.
    Garin, E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2009, 33 (06): : 363 - 374
  • [50] Positron emission tomography in oncology with use of radiotracers alternative to 18F-fluorodeoxyglucose
    Szurowska, Edyta
    Teodorczyk, Jacek
    Dziadziuszko, Katarzyna
    Pienkowska, Joanna
    Romanowicz, Grzegorz
    Lass, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2013, 9 (05): : 197 - 199